Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors

Robert Hsu, Karen Resnick, Peter Zang, Travis Larsen, Shirley Ye, April Choi, Shawn Yu, Kevin Brady, Trevor E. Angell, Lily Dara, Fumito Ito, Jorge J. Nieva, Gino K. In

Therapeutic Advances in Medical Oncology

Published online on February 28, 2026

Abstract

Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Immune checkpoint inhibitors (ICIs) have changed the treatment landscape for non-small cell lung cancer, but the role of race/ethnicity is not well understood.Design:This is a retrospective study of non-small cell lung cancer (NSCLC) patients ...